Contributors

Contributors Judy Lieberman, senior investigator at the Immune Disease Institute and the program in cellular and molecular medicine at the Children’s Hospital Boston, came to be a physician through an unusual pathway. Before attending medical school, Lieberman earned a doctorate in theoretical physics, but turned to a career in medicine so she could directly impact peoples’ lives. “I wanted to do something more socially useful,&#

Written byThe Scientist
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Judy Lieberman, senior investigator at the Immune Disease Institute and the program in cellular and molecular medicine at the Children’s Hospital Boston, came to be a physician through an unusual pathway. Before attending medical school, Lieberman earned a doctorate in theoretical physics, but turned to a career in medicine so she could directly impact peoples’ lives. “I wanted to do something more socially useful,” says Lieberman, also a professor of pediatrics at Harvard Medical School. So she began researching HIV/AIDS. After reading the 1998 paper by Andrew Fire and Craig Mello describing RNAi, she continued asking questions to see if their work would help suppress HIV. She describes what she’s found on p. 42.

Rice University sociology professor Elaine Ecklund is interested in how the public views scientists. “The popular image is that scientists are godless atheists, and that science had turned them away from religion,” she says. Intrigued by ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies